|
1
|
Smolen JS, Aletaha D and McInnes IB:
Rheumatoid arthritis. Lancet. 388:2023–2038. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Safiri S, Kolahi AA, Hoy D, Smith E,
Bettampadi D, Mansournia MA, Almasi-Hashiani A, Ashrafi-Asgarabad
A, Moradi-Lakeh M, Qorbani M, et al: Global, regional and national
burden of rheumatoid arthritis 1990-2017: A systematic analysis of
the global burden of disease study 2017. Ann Rheum Dis.
78:1463–1471. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Smolen JS, Aletaha D, Barton A, Burmester
GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH,
Strand V and Yamamoto K: Rheumatoid arthritis. Nat Rev Dis Primers.
4(18001)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Orsolini G, Fassio A, Rossini M, Adami G,
Giollo A, Caimmi C, Idolazzi L, Viapiana O and Gatti D: Effects of
biological and targeted synthetic DMARDs on bone loss in rheumatoid
arthritis. Pharmacol Res. 147(104354)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lazzerini PE, Capecchi PL and Laghi-Pasini
F: Systemic inflammation and arrhythmic risk: Lessons from
rheumatoid arthritis. Eur Heart J. 38:1717–1727. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li Y, Jiang L, Zhang Z, Li H, Jiang L,
Wang L and Li Z: Clinical characteristics of rheumatoid arthritis
patients with peripheral neuropathy and potential related risk
factors. Clin Rheumatol. 38:2099–2107. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Scott DL, Wolfe F and Huizinga TWJ:
Rheumatoid arthritis. Lancet. 376:1094–1108. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lundberg K, Bengtsson C, Kharlamova N,
Reed E, Jiang X, Kallberg H, Pollak-Dorocic I, Israelsson L, Kessel
C, Padyukov L, et al: Genetic and environmental determinants for
disease risk in subsets of rheumatoid arthritis defined by the
anticitrullinated protein/peptide antibody fine specificity
profile. Ann Rheum Dis. 72:652–658. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
McInnes IB and Schett G: The pathogenesis
of rheumatoid arthritis. N Engl J Med. 365:2205–2219.
2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Falconer J, Murphy AN, Young SP, Clark AR,
Tiziani S, Guma M and Buckley CD: Review: Synovial cell metabolism
and chronic inflammation in rheumatoid arthritis. Arthritis
Rheumatol. 70:984–999. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen X, Zhang L, Song Q and Chen Z:
MicroRNA-216b regulates cell proliferation, invasion and cycle
progression via interaction with cyclin T2 in gastric cancer.
Anticancer Drugs. 31:623–631. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bragg R, Gilbert W, Elmansi AM, Isales CM,
Hamrick MW, Hill WD and Fulzele S: Stromal cell-derived factor-1 as
a potential therapeutic target for osteoarthritis and rheumatoid
arthritis. Ther Adv Chronic Dis.
10(2040622319882531)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mathiessen A and Conaghan PG: Synovitis in
osteoarthritis: Current understanding with therapeutic
implications. Arthritis Res Ther. 19(18)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Scanzello CR and Goldring SR: The role of
synovitis in osteoarthritis pathogenesis. Bone. 51:249–257.
2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tan HL, Chan KG, Pusparajah P, Saokaew S,
Duangjai A, Lee LH and Goh BH: Anti-cancer properties of the
naturally occurring aphrodisiacs: Icariin and its derivatives.
Front Pharmacol. 7(191)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang B, Wang G, He J, Yang Q, Li D, Li J
and Zhang F: Icariin attenuates neuroinflammation and exerts
dopamine neuroprotection via an Nrf2-dependent manner. J
Neuroinflammation. 16(92)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zheng Y, Zhu G, He J, Wang G, Li D and
Zhang F: Icariin targets Nrf2 signaling to inhibit
microglia-mediated neuroinflammation. Int Immunopharmacol.
73:304–311. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang GQ, Li DD, Huang C, Lu DS, Zhang C,
Zhou SY, Liu J and Zhang F: Icariin reduces dopaminergic neuronal
loss and microglia-mediated inflammation in vivo and in vitro.
Front Mol Neurosci. 10(441)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zu Y, Mu Y, Li Q, Zhang ST and Yan HJ:
Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated
pyroptosis. J Orthop Surg Res. 14(307)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Huang H, Zhang ZF, Qin FW, Tang W, Liu DH,
Wu PY and Jiao F: Icariin inhibits chondrocyte apoptosis and
angiogenesis by regulating the TDP-43 signaling pathway. Mol Genet
Genomic Med. 7(e00586)2019.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Wang P, Xiong X, Zhang J, Qin S, Wang W
and Liu Z: Icariin increases chondrocyte vitality by promoting
hypoxia-inducible factor-1α expression and anaerobic glycolysis.
Knee. 27:18–25. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shen R and Wang JH: The effect of icariin
on immunity and its potential application. Am J Clin Exp Immunol.
7:50–56. 2018.PubMed/NCBI
|
|
23
|
Chi L, Gao W, Shu X and Lu X: A natural
flavonoid glucoside, icariin, regulates Th17 and alleviates
rheumatoid arthritis in a murine model. Mediators Inflamm.
2014(392062)2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cheleschi S, Gallo I, Barbarino M,
Giannotti S, Mondanelli N, Giordano A, Tenti S and Fioravanti A:
MicroRNA mediate visfatin and resistin induction of oxidative
stress in human osteoarthritic synovial fibroblasts via NF-κB
pathway. Int J Mol Sci. 20(5200)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Franz A, Joseph L, Mayer C, Harmsen JF,
Schrumpf H, Frobel J, Ostapczuk MS, Krauspe R and Zilkens C: The
role of oxidative and nitrosative stress in the pathology of
osteoarthritis: Novel candidate biomarkers for quantification of
degenerative changes in the knee joint. Orthop Rev (Pavia).
10(7460)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ostalowska A, Birkner E, Wiecha M,
Kasperczyk S, Kasperczyk A, Kapolka D and Zon-Giebel A: Lipid
peroxidation and antioxidant enzymes in synovial fluid of patients
with primary and secondary osteoarthritis of the knee joint.
Osteoarthritis Cartilage. 14:139–145. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–379. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang M, Liu J, Guo W, Liu X, Liu S and
Yin H: Icariin regulates systemic iron metabolism by increasing
hepatic hepcidin expression through Stat3 and Smad1/5/8 signaling.
Int J Mol Med. 37:1379–1388. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yin S, Wang P, Xing R, Zhao L, Li X, Zhang
L and Xiao Y: Transient receptor potential ankyrin 1 (TRPA1)
mediates lipopolysaccharide (LPS)-induced inflammatory responses in
primary human osteoarthritic fibroblast-like synoviocytes.
Inflammation. 41:700–709. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tsikas D: Assessment of lipid peroxidation
by measuring malondialdehyde (MDA) and relatives in biological
samples: Analytical and biological challenges. Anal Biochem.
524:13–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Srivastava NK, Sharma S, Sinha N, Mandal
SK and Sharma D: Abnormal lipid metabolism in a rat model of
arthritis: One possible pathway. Mol Cell Biochem. 448:107–124.
2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Luczaj W, Jarocka-Karpinska I, Sierakowski
S, Andrisic L, Zarkovic N and Skrzydlewska E: Lipid peroxidation in
Rheumatoid arthritis; consequences and monitoring. Free Radic Biol
Med. 75 (Suppl 1)(S49)2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Winyard PG, Blake DR, Chirico S,
Gutteridge JM and Lunec J: Mechanism of exacerbation of rheumatoid
synovitis by total-dose iron-dextran infusion: In-vivo
demonstration of iron-promoted oxidant stress. Lancet. 1:69–72.
1987.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Morris CJ, Wainwright AC, Steven MM and
Blake DR: The nature of iron deposits in haemophilic synovitis. An
immunohistochemical, ultrastructural and X-ray microanalytical
study. Virchows Arch A Pathol Anat Histopathol. 404:75–85.
1984.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang C, Zhang W, Shi R, Tang B and Xie S:
Coix lachryma-jobi extract ameliorates inflammation and oxidative
stress in a complete Freund's adjuvant-induced rheumatoid arthritis
model. Pharm Biol. 57:792–798. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yang L, Wang H, Yang X, Wu Q, An P, Jin X,
Liu W, Huang X, Li Y, Yan S, et al: Auranofin mitigates systemic
iron overload and induces ferroptosis via distinct mechanisms.
Signal Transduct Target Ther. 5(138)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yang WS and Stockwell BR: Ferroptosis:
Death by lipid peroxidation. Trends Cell Biol. 26:165–176.
2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kawabata H: Transferrin and transferrin
receptors update. Free Radic Biol Med. 133:46–54. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Dodson M, Castro-Portuguez R and Zhang DD:
NRF2 plays a critical role in mitigating lipid peroxidation and
ferroptosis. Redox Biol. 23(101107)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zhou B, Liu J, Kang R, Klionsky DJ,
Kroemer G and Tang D: Ferroptosis is a type of autophagy-dependent
cell death. Semin Cancer Biol. 66:89–100. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Imai H, Matsuoka M, Kumagai T, Sakamoto T
and Koumura T: Lipid peroxidation-dependent cell death regulated by
GPx4 and ferroptosis. Curr Top Microbiol Immunol. 403:143–170.
2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Pan L, Zhang Y, Chen N and Yang L: Icariin
regulates cellular functions and gene expression of osteoarthritis
patient-derived human fibroblast-like synoviocytes. Int J Mol Sci.
18(2656)2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Su Y, Zhao B, Zhou L, Zhang Z, Shen Y, Lv
H, AlQudsy LH and Shang P: Ferroptosis, a novel pharmacological
mechanism of anti-cancer drugs. Cancer Lett. 483:127–136.
2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Spasić S, Nikolić-Kokić A, Miletić S,
Oreščanin-Dušić Z, Spasić MB, Blagojević D and Stević Z: Edaravone
may prevent ferroptosis in ALS. Curr Drug Targets. 21:776–780.
2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Xu M, Tao J, Yang Y, Tan S, Liu H, Jiang
J, Zheng F and Wu B: Ferroptosis involves in intestinal epithelial
cell death in ulcerative colitis. Cell Death Dis.
11(86)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Łuczaj W, Gindzienska-Sieskiewicz E,
Jarocka-Karpowicz I, Andrisic L, Sierakowski S, Zarkovic N, Waeg G
and Skrzydlewska E: The onset of lipid peroxidation in rheumatoid
arthritis: Consequences and monitoring. Free Radic Res. 50:304–313.
2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Olszewska-Slonina DM, Jung S, Olszewski
KJ, Cwynar A and Drewa G: Evaluation of selected parameters of
lipid peroxidation and paraoxonase activity in blood of patients
with joint osteoarthritis. Protein Pept Lett. 25:853–861.
2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Morris CJ, Blake DR, Wainwright AC and
Steven MM: Relationship between iron deposits and tissue damage in
the synovium: An ultrastructural study. Ann Rheum Dis. 45:21–26.
1986.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ogilvie-Harris DJ and Fornaiser VL:
Synovial iron deposition in osteoarthritis and rheumatoid
arthritis. J Rheumatol. 7:30–36. 1980.PubMed/NCBI
|
|
50
|
Bennett RM, Williams ED, Lewis SM and Holt
PJ: Synovial iron deposition in rheumatoid arthritis. Arthritis
Rheum. 16:298–304. 1973.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Grigolo B, Roseti L, Fiorini M and
Facchini A: Enhanced lipid peroxidation in synoviocytes from
patients with osteoarthritis. J Rheumatol. 30:345–347.
2003.PubMed/NCBI
|
|
52
|
Grönwall C, Amara K, Hardt U,
Krishnamurthy A, Steen J, Engström M, Sun M, Ytterberg AJ, Zubarev
RA, Scheel-Toellner D, et al: Autoreactivity to
malondialdehyde-modifications in rheumatoid arthritis is linked to
disease activity and synovial pathogenesis. J Autoimmun. 84:29–45.
2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Surapneni KM and Chandrasada Gopan VS:
Lipid peroxidation and antioxidant status in patients with
rheumatoid arthritis. Indian J Clin Biochem. 23:41–44.
2008.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Sutipornpalangkul W, Morales NP,
Charoencholvanich K and Harnroongroj T: Lipid peroxidation,
glutathione, vitamin E, and antioxidant enzymes in synovial fluid
from patients with osteoarthritis. Int J Rheum Dis. 12:324–328.
2009.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Fritz P, Saal JG, Wicherek C, König A,
Laschner W and Rautenstrauch H: Quantitative photometrical
assessment of iron deposits in synovial membranes in different
joint diseases. Rheumatol Int. 15:211–216. 1996.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Bennett RM: Synovial iron deposition in
osteoarthritis and rheumatoid arthritis. J Rheumatol.
7(583)1980.PubMed/NCBI
|
|
57
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cell Mol Life Sci. 73:2195–2209. 2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Shin D, Kim EH, Lee J and Roh JL: Nrf2
inhibition reverses resistance to GPX4 inhibitor-induced
ferroptosis in head and neck cancer. Free Radic Biol Med.
129:454–462. 2018.PubMed/NCBI View Article : Google Scholar
|
